Table 1.
Body mass average during the study.
| Groups | Days of Study | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 30 | 32 | 34 | 36 | 38 | 40 | |
| CT | 317.0 g | 427.9 g | 436.5 g | 443.7 g | 449.5 g | 451.8 g | 461.4 g |
| DX1.25 | 339.4 g | 433.9 g | 414.1 g | 390.4 g *** | 367.4 g *** | 348.0 g *** | 336.7 g *** |
| DX2.5 | 328.1 g | 443.3 g | 422.9 g | 398.0 g ** | 374.6 g *** | 357.1 g *** | 335.5 g *** |
| DC10 | 317.5 g | 418.2 g | 380.2 g*** | 379.7 g *** | 368.5 g *** | 355.3 g *** | 353.0 g *** |
| DC20 | 320.3 g | 433.2 g | 398.4 g ** | 385.0 g*** | 365.2 g *** | 350.0 g *** | 339.8 g *** |
| MP6 | 336.6 g | 439.0 g | 400.5 g * | 368.5 g *** | 346.0 g *** | 323.4 g *** | 317.0 g *** |
| MP13 | 319.1 g | 436.0 g | 388.1 g *** | 354.8 g *** ## vs. DX2.5 |
331.4 g *** ## vs. DX2.5 |
313.1 g *** ## vs. DX2.5 # vs. DC20 |
293.4 g *** ## vs. DX2.5 ## vs. DC20 |
Asterisks represent the statistical analysis in comparison to the CT group or to the indicated group at each time of different glucocorticoids’ administration. * or # = P < 0.05; ** or ## = P < 0.01 and *** = P < 0.001 (n per group: CT = 10, DX1.25 = 9, DX2.5 = 8, DC10 = 10, DC20 = 10, MP13 = 8, MP6 = 8). A repeated-measures ANOVA, followed by the Bonferroni post hoc test, was used.